EPN-V2

DATA3740 IT-Innovation and entrepreneurship project Course description

Course name in Norwegian
IT-Innovasjons- og entreprenørskapsprosjekt
Weight
10.0 ECTS
Year of study
2024/2025
Course history
  • Introduction

    The following coursework is compulsory and must be approved before the student can sit the exam:

    • three big group assignments (3-5 students) where the students demonstrate their understanding of the course literature. The groups are expected to submit papers that clearly show that they have discussed and reflected on the assignments.
  • Recommended preliminary courses

    The course builds on computer science courses from the first year of the programme.

  • Required preliminary courses

    After completing the course, the student should have the following learning outcomes defined in terms of knowledge, skills and general competence:

    Knowledge

    The student

    • can describe the structure and function of biological barriers
    • can explain the function of relevant ancillary substances in pharmaceutical preparations
    • is capable of explaining factors that can limit the bioavailability of active ingredients and influence the biopharmaceutical properties of pharmaceuticals
    • can explain the choice of active ingredients, formulation and route of administration in connection with pharmaceutical development
    • can give grounds for how the durability and conditions for storage of pharmaceuticals are determined
    • is capable of assessing the use of different pharmaceutical formulations based on a patient’s condition and needs

    Skills

    The student

    • can discuss principles of pharmaceutical formulation based on information from summaries of product characteristics (SPC) and any other relevant pharmaceutical reference works
    • masters basic skills in aseptic work technique and sterilisation procedures
    • can assess whether a pharmaceutical batch is consistent with specific quality requirements
    • can present an allocated relevant topic to fellow students

    General competence

    The student

    • can apply knowledge to identify innovative formulations and critical stages of the development and production of pharmaceuticals
    • can familiarise him/herself with the principles of formulation for new pharmaceuticals
    • can assess possibilities for individual adaptation of pharmaceutical formulation to create the best possible health at the individual level
    • has a conscious relationship to the choice of own formulation and routes of administration
    • has an understanding of the role of the pharmacist in pharmaceutical development and production
  • Learning outcomes

    Work and teaching methods include lectures, group work, question sessions and laboratory work. The lectures involve student activity and the material elucidated with the help of examples of clinical relevance. The laboratory work focuses on aseptic work technique. The flipped classroom method is used for parts of the course. Digital learning resources will be made available to students in advance, and the time they spend at the university will be used to work on assignments and group work.

  • Teaching and learning methods

    The following must have been approved in order for the student to take the exam:

    • Minimum attendance of 90% in the laboratory course in the production of pharmaceuticals subject to sterility requirements
    • Individual practical test in the production of pharmaceuticals subject to sterility requirements, up to 2 hours

    If the practical test is not approved, arrangements will be made for another attempt before the ordinary exam. Approval is required in order for the student to be able to take the ordinary exam. Students are entitled to a third attempt before the resit/rescheduled exam.  If a piece of required coursework is not approved, this may lead to delayed progress in the programme. 

  • Course requirements

    Supervised individual written exam, 4 hours

  • Assessment

    Calculators, all types

  • Permitted exam materials and equipment

    Grade scale A-F

  • Grading scale

    All exams are assessed by two examiners. At least 30% of the exam papers will be assessed by an external examiner. The external examiner’s assessment should benefit all the students.

  • Examiners

    Subjects covered by the course, with credits specified:

    • Biopharmaceutics and pharmaceutical science 10 credits